Gilead Sciences, Inc. (LON:0QYQ)
116.73
-0.67 (-0.57%)
At close: Oct 9, 2025
Gilead Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Cash & Equivalents | 5,144 | 9,991 | 6,085 | 5,412 | 5,338 | 5,997 | Upgrade |
Short-Term Investments | 69 | - | 1,179 | 973 | 1,182 | 1,411 | Upgrade |
Cash & Short-Term Investments | 5,213 | 9,991 | 7,264 | 6,385 | 6,520 | 7,408 | Upgrade |
Cash Growth | 88.06% | 37.54% | 13.77% | -2.07% | -11.99% | -69.58% | Upgrade |
Accounts Receivable | 4,781 | 4,420 | 4,660 | 4,777 | 4,493 | 4,892 | Upgrade |
Inventory | 1,825 | 1,710 | 1,787 | 1,507 | 1,618 | 1,683 | Upgrade |
Other Current Assets | 2,899 | 3,052 | 2,374 | 1,774 | 2,141 | 2,013 | Upgrade |
Total Current Assets | 14,718 | 19,173 | 16,085 | 14,443 | 14,772 | 15,996 | Upgrade |
Net Property, Plant & Equipment | 5,459 | 5,414 | 5,317 | 5,475 | 5,121 | 4,967 | Upgrade |
Other Intangible Assets | 18,566 | 19,948 | 26,454 | 28,894 | 33,455 | 33,126 | Upgrade |
Goodwill | 8,314 | 8,314 | 8,314 | 8,314 | 8,332 | 8,108 | Upgrade |
Long-Term Investments | 1,913 | - | 1,163 | 1,245 | 1,309 | 502 | Upgrade |
Other Long-Term Assets | 6,752 | 6,147 | 4,792 | 4,800 | 4,963 | 5,708 | Upgrade |
Total Assets | 55,721 | 58,995 | 62,125 | 63,171 | 67,952 | 68,407 | Upgrade |
Accounts Payable | 582 | 833 | 550 | 905 | 705 | 844 | Upgrade |
Accrued Expenses | 4,215 | 3,892 | 3,802 | 3,479 | 3,244 | 3,460 | Upgrade |
Current Portion of Long-Term Debt | 2,806 | 1,815 | 1,798 | 2,273 | 1,516 | 2,757 | Upgrade |
Other Current Liabilities | 3,586 | 5,464 | 5,130 | 4,580 | 6,145 | 4,336 | Upgrade |
Total Current Liabilities | 11,189 | 12,004 | 11,280 | 11,237 | 11,610 | 11,397 | Upgrade |
Long-Term Debt | 22,140 | 24,896 | 23,189 | 22,957 | 25,179 | 28,645 | Upgrade |
Other Long-Term Liabilities | 2,801 | 2,849 | 4,907 | 7,768 | 10,099 | 10,144 | Upgrade |
Total Long-Term Liabilities | 24,941 | 27,745 | 28,096 | 30,725 | 35,278 | 38,789 | Upgrade |
Total Liabilities | 36,130 | 39,749 | 39,376 | 41,962 | 46,888 | 50,186 | Upgrade |
Common Stock | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade |
Additional Paid-in Capital | 8,367 | 7,700 | 6,500 | 5,550 | 4,661 | 3,880 | Upgrade |
Accumulated Other Comprehensive Income | -18 | 132 | 28 | 2 | 83 | -60 | Upgrade |
Retained Earnings | 11,325 | 11,497 | 16,304 | 15,687 | 16,324 | 14,381 | Upgrade |
Total Common Shareholders' Equity | 19,674 | 19,330 | 22,833 | 21,240 | 21,069 | 18,202 | Upgrade |
Minority Interest | -84 | -84 | -84 | -31 | -5 | 19 | Upgrade |
Shareholders' Equity | 19,590 | 19,246 | 22,749 | 21,209 | 21,064 | 18,221 | Upgrade |
Total Liabilities & Equity | 55,721 | 58,995 | 62,125 | 63,171 | 67,952 | 68,407 | Upgrade |
Total Debt | 24,946 | 26,711 | 24,987 | 25,230 | 26,695 | 31,402 | Upgrade |
Net Cash (Debt) | -19,733 | -16,720 | -17,723 | -18,845 | -20,175 | -23,994 | Upgrade |
Net Cash Per Share | -15.64 | -13.32 | -14.09 | -14.93 | -15.99 | -19.00 | Upgrade |
Book Value | 19,674 | 19,330 | 22,833 | 21,240 | 21,069 | 18,202 | Upgrade |
Book Value Per Share | 15.59 | 15.40 | 18.15 | 16.83 | 16.69 | 14.41 | Upgrade |
Tangible Book Value | -7,206 | -8,932 | -11,935 | -15,968 | -20,718 | -23,032 | Upgrade |
Tangible Book Value Per Share | -5.71 | -7.12 | -9.49 | -12.65 | -16.42 | -18.24 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.